Celldex Therapeutics, Inc. (CLDX) Current Reports & Earnings Releases
Upcoming
- 2026-11-09 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-06-26 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-02 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-25 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-19 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-06 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-01 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.